Lapse and Mortality of Post-Level Period Term Plans Tim Rozar FSA, MAAA, CERA Derek Kueker FSA International Actuarial Association Background 2 Introduction to Post-Level Term 10-Year Term: Premium Structure with Jump to ART 10-Year Term - Sample Premium Structure Male Age 45, $500,000 Death Benefit Super-Preferred Non-Smoker 18,000 16,000 14,000 Annual Premium 12,000 $7,395 Duration 11 Premium 10,000 8,000 20 times Premium Jump 6,000 4,000 $375 Level Premium 2,000 1 2 3 4 5 6 7 8 9 10 11 Level Period 12 13 14 15 16 17 18 19 20 Post-Level Period Duration 3 Who Pays the $7,395 Rather Than Dropping Coverage or Getting a New Policy? The Sick… The Lazy… …And ALL 3 have extra mortality risk! The Unaware… 4 • Sharp increase in premium after level period leads to large anti-selective shock lapse. Lapse Rate 70% 60% 50% 40% 30% 20% 10% 0% 6 7 8 9 10 11 Level Period 300% • Mortality on persisting policyholders is substantially worse in the post-level period. 12 13+ Tail Period 2008 VBT Mortality Ratio 250% 200% 150% 100% 50% 0% 6 7 8 9 Level Period 10 11 12 13+ Tail Period 5 SOA/RGA Post-Level Term Study Lapse Study Experience Results 6 Shock Lapse Experience Results Overview 2000-2012 Policy-Year Study 2014 Study 2010 Study Change Number of Companies w/ Post Level Experience 10-Year Term Post-Level Lapses with Premiums Post-Level Lapses without Premiums 36 436,307 258,030 25 87,544 170,171 144% 498% 152% Number of Companies w/ Post Level Experience 15-Year Term Post-Level Lapses with Premiums Post-Level Lapses without Premiums 15 37,673 1,364 7 12,191 1,359 214% 309% 100% 7 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Duration 100% 1,000,000 90% Lapse Rate 70% 10,000 60% 50% 1,000 40% 100 30% 20% Number of Lapses 100,000 80% 10 10% 0% 1 6 7 8 9 10 11 Level Period Lapse Rate 12 13 14 15 16+ Post-Level Period Median Lapse Rate Number of Lapses (right axis) 8 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience T15 By Duration 100% 100,000 90% 10,000 Lapse Rate 70% 60% 1,000 50% 40% 100 30% 20% Number of Lapses 80% 10 10% 0% 1 11 12 13 14 15 Level Period Lapse Rate Median Lapse Rate 16 17 18 19+ Post-Level Period Number of Lapses (right axis) 9 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Premium Jump Ratio 100,000 100% 90% Lapse Rate 70% 1,000 60% 50% 100 40% 30% Number of Lapses 10,000 80% 10 20% 10% 1 0% Duration 11/10 Premium Jump Ratio Duration 10 Lapse Rate Count Duration 10 Lapses 10 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Duration & Premium Jump 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Duration Duration 10 Lapse Rate 11/10Duration Premium Jump 11 Lapse Rate Ratio Duration 12 Lapse Rate 11 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Duration & Premium Jump 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Duration 10 Lapse Rate Duration 11 Lapse Rate Dur 11 / Dur 10 Dur 12 / Dur 11 Duration 11/10 Premium Jump Ratio Duration 11/10 Premium Jump Ratio Band Dur 11 / Dur 10 Dur 12 / Dur 11 1.01x - 2x 2.01x - 3x 3.01x - 4x 4.01x - 5x 5.01x - 6x 6.01x - 7x 7.01x - 8x 8.01x - 9x 9.01x - 10x 10.01x-12x 12.01x-14x 14.01x-16x 16.01x + Subtotal Prem Data Available No Prem Data Available Grand Total 79.5% 77.0% 73.2% 73.1% 70.5% 73.5% 73.2% 74.5% 78.7% 79.1% 79.7% 82.9% 86.0% 59.4% 55.0% 57.4% 59.5% 46.7% 44.9% 42.7% 45.4% 45.1% 46.3% 45.9% 54.7% 49.7% 49.4% 56.8% 59.8% 42.9% 43.1% 42.9% Duration 12 Lapse Rate 12 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience T10 By Duration and Issue Age 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 0-19 20-29 30-39 40-49 50-59 60-69 70+ Issue Age Duration 6-9 Duration 10 Duration 11 Duration 12+ 13 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Premium Jump and Issue age – duration 10 100% 100,000 90% 80% 10,000 70% 1,000 50% 40% 100 30% 20% Number of Lapses Lapse Rate 60% 10 10% 0% 1 <40 40-49 50-59 60+ <40 40-49 50-59 60+ <40 40-49 50-59 60+ <40 40-49 50-59 60+ <40 40-49 50-59 60+ 1.01x - 3x 3.01x - 5x 5.01x - 7x 7.01x - 9x 9.01x + Duration 10 Lapse Rate Duration 10 Lapses Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx 14 Shock Lapse Experience T10 By Duration & Face Amount Band 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% < $50,000 $50,000 $99,999 $100,000 $249,999 $250,000 $999,999 $1,000,000 $4,999,999 $5,000,000 + Face Amount Duration 6-9 Duration 10 Duration 11 Duration 12+ 15 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience (Jump to ART) T10 By Premium Jump and Face Amount Band – duration 10 100% 100,000 90% 80% 10,000 70% 1,000 50% 40% 100 30% 20% Number of Lapses Lapse Rate 60% 10 10% 0% 1 <100k 100k- 250k- 1M+ <100k 100k- 250k- 1M+ <100k 100k- 250k- 1M+ <100k 100k- 250k- 1M+ <100k 100k- 250k- 1M+ 249k 999k 249k 999k 249k 999k 249k 999k 249k 999k 1.01x - 3x 3.01x - 5x Duration 10 Lapse Rate 5.01x - 7x 7.01x - 9x 9.01x + Duration 10 Lapses 16 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience T10 By Duration & Gender 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Male Female Gender Duration 6-9 Duration 10 Duration 11 Duration 12+ 17 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience T10 By Duration & Risk Class 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Super-Preferred Preferred Non-Preferred Undiff Preferred Non-Preferred Non-Smoker Undiff Smoker Unk/Agg Risk Class Duration 6-9 Duration 10 Duration 11 Duration 12+ 18 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Shock Lapse Experience T10 By Duration & Premium Payment Mode 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Annual Semi-Annual Quarterly Monthly Premium Payment Mode Duration 6-9 Duration 10 Duration 11 Duration 12+ 19 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx SOA/RGA Post-Level Term Study Mortality Study Experience Results 20 Mortality Experience Overview 2000-2012 Calendar Year Study 2014 Study 2010 Study Change Number of Companies w/ Post Level Experience 10-Year Term Post-Level Claims with Premiums Post-Level Claims without Premiums 36 2,651 729 24 382 381 150% 694% 191% Number of Companies w/ Post Level Experience 15-Year Term Post-Level Claims with Premiums Post-Level Claims without Premiums 6 432 12 5 145 13 120% 298% 92% 21 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Experience (Jump to ART) T10 By Duration 450% 10,000 400% 1,000 300% 250% 100 200% 150% 10 100% Number of Deaths Mortality Relative to Durations 6-10 350% 50% 0% 1 6 7 8 9 10 11 Level Period A/E Mortality 12 13 14 15 16+ Post-Level Period Median A/E Mortality Number of Deaths (right axis) 22 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Experience T15 By Duration 450% 10,000 400% 1,000 300% 250% 100 200% 150% Number of Deaths Mortality Relative to Durations 11-15 350% 10 100% 50% 0% 1 11 12 13 14 15 Level Period A/E Mortality Median AE Rate 16 17 18 19+ Post-Level Period Number of Deaths (right axis) 23 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Experience (Jump to ART) T10 Duration 11 Mortality by Premium Jump 2000% 10,000 1800% 1600% 1,000 Mortality Relative to Durations 6-10 1200% 1000% 100 800% 600% Number of Deaths 1400% 10 400% 200% 0% 1 1.01x 2x 2.01x 3x 3.01x 4x 4.01x 5x 5.01x 6x 6.01x 7x 7.01x 8x 8.01x 9x 9.01x 12x 12.01x- 15.01x- 18.01x + 15x 18x Duration 11/10 Premium Jump Ratio Relative Mortality Ratio Number of Deaths (right axis) Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx 24 Mortality Experience (Jump to ART) T10 Duration 11+ Mortality by Issue Age 400% 350% 300% 250% 200% 150% 100% 50% 0% 0-29 30-39 40-49 50-59 60+ Issue Age Duration 6-10 Duration 11+ Post-Level Relative to Dur 6-10 25 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Experience (Jump to ART) T10 Duration 11+ Mortality by Face Amount Band 500% 450% 400% 350% 300% 250% 200% 150% 100% 50% 0% < $50,000 $50,000 $99,999 Duration 6-10 $100,000 $250,000 $249,999 $999,999 Face Amount Band Duration 11+ $1,000,000 + Post-Level Relative to Dur 6-10 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx 26 Mortality Study Experience Results – Jump to ART T10 Duration 11+ Mortality by Gender 350% 300% 250% 200% 150% 100% 50% 0% Male Duration 6-10 Gender Duration 11+ Female Post-Level Relative to Dur 6-10 27 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Study Experience Results – Jump to ART T10 Duration 11+ Mortality by Risk Class 550% 500% 450% 400% 350% 300% 250% 200% 150% 100% 50% 0% SuperPreferred Preferred Non-Preferred Undiff Preferred Non-Smoker Non-Preferred Undiff Smoker Unk/Agg Risk Class Duration 6-10 Duration 11+ Post-Level Relative to Dur 6-10 28 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Mortality Experience (Jump to ART) T10 Duration 11 Mortality by Duration 10 Shock Lapse by Company 1500% Duration 11 Mortality Relative to Duraitons 6-10 1350% 1200% 1050% 900% 750% >=35 claims 600% <35 claims Expon. () 450% 300% 150% 0% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Duration 10 Shock Lapse Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx 29 Practical Applications 30 Shock Lapse Experience Skewness of Lapses 100% 90% 12 80% Proportion of Lapses 11 70% 10 60% 9 8 50% 7 6 40% 5 30% 4 20% 3 10% 2 1 0% 6-9 10 11 12+ Duration 31 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx Grace Period Subsidy • Grace period creates mismatch between exposure basis for claims and premiums • No duration 11 premium received, but effective duration 10 exposure extends into grace period. • Premium-paying persisters must subsidize “free insurance” during the grace period for policyholders who intended to lapse on their anniversary. • Much bigger impact with shock lapse • Small number of premium-payers…lots of lapsers • Magnitude increases for higher lapse rates or longer grace periods 32 Grace Period Subsidy - Example • Assumptions: • Cohort mortality = 0.1 / 1000 monthly in durations 10 & 11 • Lapse on anniversary at end of duration 10 • All lapsers will passively lapse and enter the grace period • 2-month grace period 33 Grace Period Subsidy – Example 5% Lapse Rate; No Anti-Selection No Grace Period Duration BOM Monthly Year Month Lives Mort Rate 10 1 100,000 0.10 10 2 99,990 0.10 10 3 99,980 0.10 10 4 99,970 0.10 10 5 99,960 0.10 10 6 99,950 0.10 10 7 99,940 0.10 10 8 99,930 0.10 10 9 99,920 0.10 10 10 99,910 0.10 10 11 99,900 0.10 10 12 99,890 0.10 11 1 94,886 0.10 11 2 94,877 0.10 11 3 94,867 0.10 11 4 94,858 0.10 11 5 94,848 0.10 11 6 94,839 0.10 11 7 94,829 0.10 11 8 94,820 0.10 11 9 94,810 0.10 11 10 94,801 0.10 11 11 94,791 0.10 11 12 94,782 0.10 10 11 Total Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 Lapses (Anniv) 4,994 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.9 4,994 94,886 1.20 113.8 194,886 1.20 233.7 4,994 Duration 11/10: 100% w/ Grace Period Experience Study Basis w/ Grace Period BOM Lives 100,000 99,990 99,980 99,970 99,960 99,950 99,940 99,930 99,920 99,910 99,900 99,890 99,880 99,870 94,867 94,858 94,848 94,839 94,829 94,820 94,810 94,801 94,791 94,782 Monthly Mort Rate 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 Lapses (Anniv) 4,993 BOM Monthly Lives Mort Rate 100,000 0.10 99,990 0.10 99,980 0.10 99,970 0.10 99,960 0.10 99,950 0.10 99,940 0.10 99,930 0.10 99,920 0.10 99,910 0.10 99,900 0.10 99,890 0.10 94,887 0.10 94,877 0.10 94,867 0.10 94,858 0.10 94,848 0.10 94,839 0.10 94,829 0.10 94,820 0.10 94,810 0.10 94,801 0.10 94,791 0.10 94,782 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 9.5 Lapses (Anniv) 4,993 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.93 4,993 94,887 1.21 114.80 194,887 1.20 234.73 4,993 Duration 11/10: 101% 34 Grace Period Subsidy – Example 60% Lapse Rate; No Anti-Selection No Grace Period Duration BOM Monthly Year Month Lives Mort Rate 10 1 100,000 0.10 10 2 99,990 0.10 10 3 99,980 0.10 10 4 99,970 0.10 10 5 99,960 0.10 10 6 99,950 0.10 10 7 99,940 0.10 10 8 99,930 0.10 10 9 99,920 0.10 10 10 99,910 0.10 10 11 99,900 0.10 10 12 99,890 0.10 11 1 39,952 0.10 11 2 39,948 0.10 11 3 39,944 0.10 11 4 39,940 0.10 11 5 39,936 0.10 11 6 39,932 0.10 11 7 39,928 0.10 11 8 39,924 0.10 11 9 39,920 0.10 11 10 39,916 0.10 11 11 39,912 0.10 11 12 39,908 0.10 10 11 Total Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 Lapses (Anniv) 59,928 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.9 59,928 39,952 1.20 47.9 139,952 1.20 167.9 59,928 Duration 11/10: 100% w/ Grace Period Experience Study Basis w/ Grace Period BOM Lives 100,000 99,990 99,980 99,970 99,960 99,950 99,940 99,930 99,920 99,910 99,900 99,890 99,880 99,870 39,944 39,940 39,936 39,932 39,928 39,924 39,920 39,916 39,912 39,908 Monthly Mort Rate 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 Lapses (Anniv) 59,916 BOM Monthly Lives Mort Rate 100,000 0.10 99,990 0.10 99,980 0.10 99,970 0.10 99,960 0.10 99,950 0.10 99,940 0.10 99,930 0.10 99,920 0.10 99,910 0.10 99,900 0.10 99,890 0.10 39,964 0.10 39,954 0.10 39,944 0.10 39,940 0.10 39,936 0.10 39,932 0.10 39,928 0.10 39,924 0.10 39,920 0.10 39,916 0.10 39,912 0.10 39,908 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 Lapses (Anniv) 59,916 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.93 59,916 39,964 1.50 59.90 139,964 1.28 179.84 59,916 Duration 11/10: 125% 35 Grace Period Subsidy – Example 90% Lapse Rate; No Anti-Selection No Grace Period Duration BOM Monthly Year Month Lives Mort Rate 10 1 100,000 0.10 10 2 99,990 0.10 10 3 99,980 0.10 10 4 99,970 0.10 10 5 99,960 0.10 10 6 99,950 0.10 10 7 99,940 0.10 10 8 99,930 0.10 10 9 99,920 0.10 10 10 99,910 0.10 10 11 99,900 0.10 10 12 99,890 0.10 11 1 9,988 0.10 11 2 9,987 0.10 11 3 9,986 0.10 11 4 9,985 0.10 11 5 9,984 0.10 11 6 9,983 0.10 11 7 9,982 0.10 11 8 9,981 0.10 11 9 9,980 0.10 11 10 9,979 0.10 11 11 9,978 0.10 11 12 9,977 0.10 10 11 Total Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Lapses (Anniv) 89,892 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.9 89,892 9,988 1.20 12.0 109,988 1.20 131.9 89,892 Duration 11/10: 100% w/ Grace Period Experience Study Basis w/ Grace Period BOM Lives 100,000 99,990 99,980 99,970 99,960 99,950 99,940 99,930 99,920 99,910 99,900 99,890 99,880 99,870 9,986 9,985 9,984 9,983 9,982 9,981 9,980 9,979 9,978 9,977 Monthly Mort Rate 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Lapses (Anniv) 89,874 BOM Monthly Lives Mort Rate 100,000 0.10 99,990 0.10 99,980 0.10 99,970 0.10 99,960 0.10 99,950 0.10 99,940 0.10 99,930 0.10 99,920 0.10 99,910 0.10 99,900 0.10 99,890 0.10 10,006 0.10 9,996 0.10 9,986 0.10 9,985 0.10 9,984 0.10 9,983 0.10 9,982 0.10 9,981 0.10 9,980 0.10 9,979 0.10 9,978 0.10 9,977 0.10 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Lapses (Anniv) 89,874 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.93 89,874 10,006 2.99 29.96 110,006 1.36 149.89 89,874 Duration 11/10: 250% 36 Grace Period Subsidy – Example 90% Lapse Rate; 200% Anti-Selection No Grace Period Duration BOM Monthly Year Month Lives Mort Rate 10 1 100,000 0.10 10 2 99,990 0.10 10 3 99,980 0.10 10 4 99,970 0.10 10 5 99,960 0.10 10 6 99,950 0.10 10 7 99,940 0.10 10 8 99,930 0.10 10 9 99,920 0.10 10 10 99,910 0.10 10 11 99,900 0.10 10 12 99,890 0.10 11 1 9,988 0.20 11 2 9,986 0.20 11 3 9,984 0.20 11 4 9,982 0.20 11 5 9,980 0.20 11 6 9,978 0.20 11 7 9,976 0.20 11 8 9,974 0.20 11 9 9,972 0.20 11 10 9,970 0.20 11 11 9,968 0.20 11 12 9,966 0.20 10 11 Total Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Lapses (Anniv) 89,892 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.9 89,892 9,988 2.40 23.9 109,988 1.31 143.9 89,892 Duration 11/10: 200% w/ Grace Period Experience Study Basis w/ Grace Period BOM Lives 100,000 99,990 99,980 99,970 99,960 99,950 99,940 99,930 99,920 99,910 99,900 99,890 99,880 99,870 9,986 9,984 9,982 9,980 9,978 9,976 9,974 9,972 9,970 9,968 Monthly Mort Rate 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Lapses (Anniv) 89,874 BOM Monthly Lives Mort Rate 100,000 0.10 99,990 0.10 99,980 0.10 99,970 0.10 99,960 0.10 99,950 0.10 99,940 0.10 99,930 0.10 99,920 0.10 99,910 0.10 99,900 0.10 99,890 0.10 10,006 0.10 9,996 0.10 9,986 0.20 9,984 0.20 9,982 0.20 9,980 0.20 9,978 0.20 9,976 0.20 9,974 0.20 9,972 0.20 9,970 0.20 9,968 0.20 Deaths 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Lapses (Anniv) 89,874 Exposure Mort Rate Deaths Lapses 100,000 1.20 119.93 89,874 10,006 3.99 39.93 110,006 1.45 159.86 89,874 Duration 11/10: 333% 37 Mortality Experience 350% 175 300% 150 250% 125 200% 100 150% 75 100% 50 50% 25 0% 0 1 2 3 4 5 6 7 8 9 Months since start of Duration 11 2008 VBT Mortality Ratios 10 11 Number of Deaths 2008 VBT Mortality Ratios Duration 11 Mortality by Month 12 Number of Deaths (right axis) 38 Source: http://www.soa.org/Research/Experience-Study/Ind-Life/Persistency/research-2014-post-level-shock.aspx SOA/RGA Post-Level Term Study Assumption Survey Results 39 Assumption Survey Results Overview Sent to top 100 term providers based on 2012 term insurance sales Responses from 41 companies Responses represented 62% of 2012 term sales Level Premium Term Product Mix by Level Period Product Level Period Aggregate Distribution for Respondents Number of companies where product represents at least x% of individual company's term sales x=5% x=15% x=30% 5 Year Term 1.20% 3 1 0 10 Year Term 22.70% 42 36 8 15 Year Term 8.60% 32 6 1 20 Year Term 52.00% 44 44 42 25-30 Year Term 15.10% 33 23 9 Other 0.40% 5 2 1 40 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Assumption Survey Results Post-Level Premium Structure Dominant Structure is Jump to an ART Scale Post-Level Product Design Product Structure Responses Premium jump to ART Premium grade to ART Jump to new level period Face amount decrease Product terminates Flexible Premiums (Term UL) 40 4 3 1 2 1 41 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Assumption Survey Results Expected Changes to Post-Level Premium Structure No change expected for most term new business Minimal changes reported to inforce term business Changes to Post-Level Premium Structure for Term New Business No change 23 Grade premiums into an ART scale over 'x' years 3 Other 3 Changes to Post-Level Premium Structure for Term In Force Description Lower post-level premiums Grade into an ART scale Other Implemented in last 5 years 1 3 0 Considering 5 3 2 42 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Post-Level Lapse Rate Structure Most companies assume only one shock lapse, generally grading down thereafter Lapse Rate Trend By Duration Description Duration L Shock, then level Duration L Shock, then grade down 2 Shocks, Duration L>=L+1 2 Shocks, Duration L+1>L Responses 10-Year Term 20-Year Term 8 7 12 10 6 5 3 2 43 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Factors impacting shock lapse assumptions Used a common pricing cell for consistent comparisons in upcoming charts Vary by These Parameters No Variance Issue Age & Level Period Level Period Issue Age & Risk Class Risk Class Premium Jump Ratio No Other Variance 9 5 5 2 1 1 Additional Variations Risk Class & Premium Premium Premium Mode Jump Ratio Jump Ratio 1 1 1 1 1 1 44 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Annual and cumulative lapse assumptions by duration, 10-year term 100% 100% 80th percentile Median 80% 20th percentile Lapse Rate 70% 60% 50% 90% 80% Cumulative Lapse Rate 90% 70% 60% 50% 30% 80th percentile Median 20% 20% 20th percentile 10% 10% 40% 30% 40% 0% 0% 10 11 12 13 Duration 14 15 10 11 12 13 Duration 14 15 45 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Duration 10 lapse assumptions by issue age, 10-year term 100% Lapse Rate 90% 80% 80th percentile 70% Median 60% 20th percentile 50% 2009 Median 40% 30% 20% 10% 0% 25 35 45 55 65 Issue Age 46 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Post-Level Lapse Rate Assumption by Premium Jump, 10-year term 100% 90% 80% Shock Lapse Broad range of assumptions by premium jump Trend is somewhat inconsistent with experience 70% 60% 50% 40% 30% 20% 10% 0% 0.0 5.0 10.0 15.0 20.0 25.0 30.0 Premium Jump 47 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Post-Level Mortality Deterioration Structure Assumptions vary broadly by structure of mortality deterioration Mortality Deterioration Assumption Trend By Duration Responses Description 10-Year Term 20-Year Term Level all durations 7 6 Decreasing or grade to ultimate level 13 11 Increasing then decreasing 6 1 Generally increasing 1 3 48 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Factors impacting mortality deterioration assumptions The same pricing cell that was used in the Lapse Assumptions charts is used in this section Vary by These Parameters Duration, Level Period and Issue Age Policy Duration Constant Duration and Level Period Level Period Issue Age No other Variation 6 5 4 3 2 1 Additional Variations Size of Risk Class Shock and Gender Gender Lapse 4 1 1 49 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Post-Level Mortality Methodology Dukes-MacDonald (or derivatives) and Flat Multiple are the primary assumptions used in developing mortality after the shock lapse Method of Developing Mortality Assumption Method N/A - 100% shock lapse Dukes-MacDonald or derivatives of Dukes-MacDonald Canadian Institute of Actuaries Valuation Technique Paper #2 Flat Multiple Other: Set by reinsurer/external consultant Other: Internally developed method Responses 9 14 4 13 3 3 50 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Annual mortality deterioration multiple, 10 year term Mortality Deterioration Multiple 500% 450% 80th percentile 400% Median 350% 20th percentile 300% 2009 Median 250% 200% 150% 100% 50% 0% 11 12 13 14 15 20 Duration 51 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Post-Level Mortality Assumptions vs. Premium Jump Mortality deterioration assumptions do not differ dramatically by premium jump, inconsistent with experience Mortality Deterioration Duration 11 1000% 900% 800% 700% 600% 500% 400% 300% 200% 100% 0% 0.0 5.0 10.0 15.0 20.0 25.0 30.0 Premium Jump 52 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Mortality Deterioration Assumptions Post-Level Mortality Assumptions vs. Premium Jump and Lapse Rate When split by lapse rate, it does not appear assumptions vary dramatically by premium jump 600% 500% Mortality Deterioration Duration 12 1-10X Jump 11-20X Jump 400% 20X Jump or Greater 300% 200% 100% 0% 0% 20% 40% 60% 80% 100% Cumulative Lapse Rate Duration 10 through 11 53 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf Lapse Assumptions Skewness assumptions from the level period through the postlevel period Today’s skewness assumptions do not always follow past experience Monthly Lapse Skewness During Level Premium Period Respondents Response 18 Lapses are uniformly distributed 10 Lapses occur on premium payment modes 7 Lapses occur at the end of the year 4 Other Monthly Lapse Skewness During Year of Shock Lapse 5 Lapses are uniformly distributed 3 Lapses occur on premium payment modes 17 Lapses occur at the end of the year Lapses graded toward end of the year with shock in month 12 12 Monthly Lapse Skewness During Post-Level Period Lapses are uniformly distributed Lapses occur on premium payment modes Lapses occur at the end of the year Lapses skewed to the beginning of L+1, Uniform thereafter 6 7 9 8 54 Source: http://www.soa.org/Files/Research/Projects/research-shock-lapse-survey-report.pdf SOA/RGA Post-Level Term Study Assumptions vs. Experience 55 10 11 12 Duration 13 14 60% Aggregate 50% 20th percentile Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) 100% Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Lapse Rate Survey Responses vs. Experience Study T10 Jump to ART Lapse Rates by Duration Phase 1 vs. Phase 2 90% 80% 70% 80th percentile Median 40% 30% 20% 10% 0% 15 56 Survey Responses vs. Experience Study T15 Lapse Rates by Duration Phase 1 vs. Phase 2 100% 90% 80% 80th percentile 60% Median 50% Aggregate 40% 20th percentile 30% 20% 10% Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) 0% Assumption Survey (Phase 1) Lapse Rate 70% 15 16 Duration 57 25 35 Issue Age 45 55 Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Lapse Rate Survey Responses vs. Experience Study T10 Jump to ART Duration 10 Lapse Rates by Issue Age Phase 1 vs. Phase 2 100% 90% 80% 70% 80th percentile 60% Median 50% Aggregate 40% 20th percentile 30% 20% 10% 0% 65 58 0% 11 12 13 Duration 14 Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Assumption Survey (Phase 1) Mortality Deterioration (Relative to Duration 6-10) Survey Responses vs. Experience Study T10 Jump to ART Mortality Deterioration by Duration Phase 1 vs. Phase 2 900% 800% 700% 600% 80th percentile 500% Median Aggregate 400% 20th percentile 300% 200% 100% 15 59 Survey Responses vs. Experience Study T10 Duration 11 Mortality Deterioration by Issue Age Phase 1 vs. Phase 2 1800% 1600% 1200% 80th percentile 1000% Median Aggregate 800% 20th percentile 600% 400% 200% 55 Experience Results (Phase 2) Assumption Survey (Phase 1) Experience Results (Phase 2) Experience Results (Phase 2) 45 Assumption Survey (Phase 1) 0% Assumption Survey (Phase 1) Mortality Deterioration (Relative to Duration 6-10) 1400% 65 Issue Age 60 SOA/RGA Post-Level Term Study Predictive Model 61 Predictive Model Multivariate Lapse Rate Model – T10 Duration 10 Shock Lapse Model: Generalized Linear Model (GLM) Target variable follows distribution in the exponential family Response variable = observed lapse count Follows a Poisson distribution Benefits: Elimination of possible bias from a uni-variate approach Systematic way of controlling lapse assumption complexity Transparent insight into true drivers of lapse rates Distribution of target variables 62 Predictive Model – Model 1 Model Parameter Variable Type Validation of Results Coefficient Factor P-Value Intercept - -2.676 <2.0E-16 Issue Age Numerical 0.0552 <2.0E-16 (Issue Age)^2 Numerical -0.000316 <2.0E-16 Risk Class Categorical Super-Pref NS Actual Predicted Data Actual / Lapse Lapse Proportion Predicted Rate Rate 0 1.00 0 11.3% 82.6% 82.6% 100.1% NS -0.06736 0.93 <2e-16 76.9% 69.1% 68.8% 100.4% SM -0.01296 0.99 0.0339 11.8% 63.5% 63.5% 100.0% 0 1.00 Face Amount Categorical <50K 0 1.2% 14.9% 17.9% 83.2% 50-100K 0.600 1.82 <2.0E-16 3.9% 61.8% 62.7% 98.5% 100K-250K 1.262 3.53 <2.0E-16 51.9% 67.5% 67.4% 100.1% 250K-1M 1.559 4.75 <2.0E-16 36.9% 74.4% 73.8% 100.8% >1M 1.585 4.88 <2.0E-16 6.1% 80.7% 80.4% 100.4% 0 22.9% 85.8% 85.3% 100.5% Premium Mode Categorical Annual 0 1.00 Semi/Quarter -0.1365 0.87 <2.0E-16 24.5% 74.9% 75.1% 99.7% Monthly/BiWeekly -0.3506 0.70 <2.0E-16 45.4% 56.9% 56.6% 100.5% -0.08481 0.92 <2.0E-16 7.2% 85.3% 84.8% 100.7% 0 0 Issue Age:Face Amt 50-100K -0.001288 0.3162 Issue Age:Face Amt 100-250K -0.01074 <2e-16 Issue Age:Face Amt 250K-1M -0.01653 <2e-16 -0.0172 <2e-16 Other/Unknown Cross Term Issue Age:Face Amt <50 Issue Age:Face Amt >1M Mixed 63 Predictive Model – Model 2 Model Parameter Type Variable Premium Jump Coefficient Factor P-Value Categorical - Premium Jump 1.01-2x 0 1.00 Premium Jump 2.01-3x 1.135 3.11 <2.00E-16 Premium Jump 3.01-4x 1.492 4.45 <2.00E-16 3.246 2.03E-14 Premium Jump 4.01-5x 1.826 6.21 <2.00E-16 Numerical 0.1621 <2.00E-16 Premium Jump 5.01-6x 2.082 8.02 <2.00E-16 (Issue Age)^2 Numerical -0.0006419 <2.00E-16 Premium Jump 6.01-7x 2.118 8.31 <2.00E-16 log(Issue Age) Numerical -2.7250000 <2.00E-16 Premium Jump 7.01-8x 2.176 8.81 <2.00E-16 Risk Class Categorical Premium Jump 8.01-10x 2.246 9.45 <2.00E-16 Intercept - Issue Age Super-Pref NS NS SM Face Amount 0 1.00 - Premium Jump 10.01-12x 2.304 10.01 <2.00E-16 0.03427 1.03 0.00 Premium Jump 12.01-16x 2.342 10.40 <2.00E-16 0.1205 1.13 <2.00E-16 Premium Jump 16.01-20x 2.385 10.86 <2.00E-16 Premium Jump 20.01x+ 2.356 10.55 <2.00E-16 Categorical - Cross Term Mixed 0 1.00 50-100K 0.3153 1.37 0.00 Issue Age:Premium Jump 1.01-2x 0 0 100K-250K 0.3437 1.41 <2.00E-16 Issue Age:Premium Jump 2.01-3x -0.02241 <2.00E-16 250K-1M 0.3652 1.44 <2.00E-16 Issue Age:Premium Jump 3.01-4x -0.02589 <2.00E-16 >1M 0.3645 1.44 <2.00E-16 Issue Age:Premium Jump 4.01-5x -0.03042 <2.00E-16 Issue Age:Premium Jump 5.01-6x -0.03383 <2.00E-16 <50K Premium Mode Categorical 0 1.00 - Issue Age:Premium Jump 6.01-7x -0.03381 <2.00E-16 -0.03244 0.97 0.00 Issue Age:Premium Jump 7.01-8x -0.03479 <2.00E-16 Monthly/BiWeekly -0.2755 0.76 <2.00E-16 Issue Age:Premium Jump 8.01-10x -0.03567 <2.00E-16 Other/Unknown 0.02057 1.02 0.06 Issue Age:Premium Jump 10.01-12x -0.03615 <2.00E-16 Issue Age:Premium Jump 12.01-16x -0.03665 <2.00E-16 Issue Age:Premium Jump 16.01-20x -0.03687 <2.00E-16 Issue Age:Premium Jump 20.01x+ -0.03601 <2.00E-16 Annual Semi/Quarter 64 Predictive Model – Model 1 Model Predicted vs. Actual Lapse Rate 100% 80,000 90% 70,000 80% 60,000 50,000 60% Exposure 50% Predicted 40% 40,000 30,000 Actual Exposure Lapse Rate 70% 30% 20,000 20% 10,000 10% 0% 0 0-19 20-29 30-39 40-49 50-59 60-69 70+ Issue Age 65 Predictive Model – Model 2 Model Predicted vs. Actual Lapse Rate 100% 40,000 90% 35,000 80% 30,000 60% Exposure 25,000 50% Predicted 20,000 Actual 40% Exposure Lapse Rate 70% 15,000 30% 10,000 20% 5,000 10% 0% 0 0-19 20-29 30-39 40-49 50-59 60-69 70+ Issue Age Model Predicted vs. Actual Lapse Rate 100% 18,000 90% 16,000 Exposure Lapse Rate Predicted 70% Actual 14,000 12,000 60% 10,000 50% 8,000 40% Exposure 80% 6,000 30% 4,000 20% 2,000 10% 0% 0 Premium Jump 66 Multivariate Lapse Rate Model - With Premium Jump 10-Year term Duration 10 Lapse Rate Assumptions Issue Age Risk Class Face Amount Premium Mode Premium Jump 45 NS 250K-1M Annual Premium Jump 8.01-10x Beta Coefficients (a) Model Variables Sample Value of xi (b) Sample Calculation (c) = (a) * (b) Variables Intercept 3.2460468406 1 3.2460 Issue Age 0.1620764522 45 7.2934 (Issue Age)^2 -0.0006419533 2025 (1.3000) log(issue Age) -2.7246684047 4 (10.3719) 0.0342716521 1 0.0343 0.3651595476 1 0.3652 0.0000000000 1 - 2.2456634786 1 2.2457 -0.0356704787 45 (1.6052) Risk Class NS Face Amount 250K-1M Premium Mode Annual Premium Jump Premium Jump 8.01-10x Cross Term Issue Age:Premium Jump 8.01-10x Results Linear Predictor = Sum(Beta i * x i) = Sum (c) Linear Predictor Modeled Lapse Rate = e (0.0924) 91.2% 67 2013 SOA Post-Level Term Survey Report Key Takeaways “Jump to an ART Scale” continues to be the dominant post-level structure, although some are considering changes Wide range of lapes and mortality assumptions are currently being used in the post-level period Many companies have not implemented appropriate skewness assumptions for lapses based on past experience 68 2014 SOA Post-Level Term Experience Report Key Takeaways Lapse rates beyond the level period are largely driven by the level of the premium compared to the original level premium Mortality in the post-level period is driven by the size of the shock lapse Lapses are skewed towards the end of the last duration of the level period and the beginning of the first duration after the level period Grace period can lead to excess mortality, especially at the higher shock lapse levels Advanced analytics, such as predictive modeling, can be critical in understanding the correlations of the many drivers of post-level term experience 69 Questions? 70